(the) Essence

In August 2026, (the) Essence concentrated 47.03% of sales in Vapor Pens (ranked 19 in Vapor Pens in Illinois), while Flower held 36.19% and Pre-Roll 14.74%, leaving less than 2.00% for Concentrates and just 0.06% for Edible. Year over year, category declines were steep across the board: Vapor Pens fell 63.30% and Flower dropped 75.55%, with Pre-Roll down 78.25% and Concentrates down 72.56%; month over month, Vapor Pens contracted 9.52% and Pre-Roll slipped 8.21%, compared with a smaller 3.09% decline in Flower. Despite a 4.83% YoY decrease in the brand’s average price to $28.43, Vapor Pens pricing stayed higher at $34.25 while Flower averaged $42.04; combined with the Edible crash of 98.35% YoY and 62.31% MoM, the mix implies a shift away from lower-ticket experimentation and toward a narrower core. The pattern suggests (the) Essence is leaning on a two-category spine where Vapor Pens’ 47.03% share and rank 19 anchor visibility, but the sharper YoY penalties in Pre-Roll and Edible indicate a retreat from breadth that concentrates risk in a shrinking pen and flower base.

The mixed cadence—Vapor Pens down 9.52% MoM versus Flower down 3.09% MoM alongside a 78.25% YoY Pre-Roll decline—indicates the brand’s near-term stability is more tied to Flower’s slower slide than to its share-leading pen line. With total brand sales down 71.83% YoY and a 24‑month decline of 86.32%, consolidation around Vapor Pens at 47.03% and Flower at 36.19% raises exposure to category headwinds; if Vapor Pens continue to outpace Flower in MoM decline by 6.43 percentage points, rank pressure around position 19 will likely intensify. Given the Edible base has effectively collapsed to 0.06% share and Concentrates sit at 1.98% with a 9.10% MoM drop, the portfolio now signals a defensive posture: prioritize margin management in pens relative to $34.25 pricing while using Flower’s comparatively smaller MoM contraction to stabilize volume, implying a need to recalibrate assortment rather than chase breadth in sub-2% niches.